ADURO BIOTECH INC's ticker is ADRO and the CUSIP is 00739L101.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $1,378,000 | -3.8% | 567,181 | -8.5% | 0.01% | -12.5% |
| Q2 2020 | $1,432,000 | -1.6% | 619,889 | +16.8% | 0.02% | -15.8% |
| Q1 2020 | $1,455,000 | +133.9% | 530,952 | +0.7% | 0.02% | +216.7% |
| Q4 2019 | $622,000 | +129.5% | 527,342 | +106.2% | 0.01% | +100.0% |
| Q3 2019 | $271,000 | +74.8% | 255,780 | +154.4% | 0.00% | +50.0% |
| Q2 2019 | $155,000 | -89.6% | 100,536 | -73.1% | 0.00% | -90.9% |
| Q1 2019 | $1,490,000 | +146.3% | 374,352 | +63.4% | 0.02% | +100.0% |
| Q4 2018 | $605,000 | -65.6% | 229,152 | -4.2% | 0.01% | -56.0% |
| Q3 2018 | $1,759,000 | +27.5% | 239,301 | +21.4% | 0.02% | +13.6% |
| Q2 2018 | $1,380,000 | +230.9% | 197,179 | +254.3% | 0.02% | +214.3% |
| Q4 2017 | $417,000 | +123.0% | 55,650 | +217.1% | 0.01% | +75.0% |
| Q3 2017 | $187,000 | +8.1% | 17,550 | +15.5% | 0.00% | 0.0% |
| Q2 2017 | $173,000 | -11.3% | 15,200 | -3.2% | 0.00% | +33.3% |
| Q3 2016 | $195,000 | -58.0% | 15,710 | -61.7% | 0.00% | -70.0% |
| Q2 2016 | $464,000 | -24.7% | 40,999 | -14.8% | 0.01% | -23.1% |
| Q1 2016 | $616,000 | – | 48,119 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVARD MANAGEMENT CO INC | 640,595 | $4,708,000 | 1.20% |
| BVF INC/IL | 287,776 | $2,115,000 | 0.19% |
| ORACLE INVESTMENT MANAGEMENT INC | 111,542 | $820,000 | 0.18% |
| Sofinnova Investments, Inc. | 189,579 | $1,393,000 | 0.12% |
| CENTAURUS FINANCIAL, INC. | 85 | $624,000 | 0.11% |
| Artal Group S.A. | 550,000 | $4,043,000 | 0.10% |
| Vident Investment Advisory, LLC | 305,311 | $2,244,000 | 0.09% |
| Virtus ETF Advisers LLC | 61,463 | $452,000 | 0.05% |
| Foundry Partners, LLC | 106,907 | $786,000 | 0.03% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 239,301 | $1,759,000 | 0.02% |